370 related articles for article (PubMed ID: 27881568)
1. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
[TBL] [Abstract][Full Text] [Related]
2. Atherosclerotic Burden and Heart Failure After Myocardial Infarction.
Gerber Y; Weston SA; Enriquez-Sarano M; Manemann SM; Chamberlain AM; Jiang R; Roger VL
JAMA Cardiol; 2016 May; 1(2):156-62. PubMed ID: 27437886
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36).
Mega JL; Hochman JS; Scirica BM; Murphy SA; Sloan S; McCabe CH; Merlini P; Morrow DA
Circulation; 2010 Apr; 121(16):1809-17. PubMed ID: 20385930
[TBL] [Abstract][Full Text] [Related]
5. Coronary Artery Ectasia Predicts Future Cardiac Events in Patients With Acute Myocardial Infarction.
Doi T; Kataoka Y; Noguchi T; Shibata T; Nakashima T; Kawakami S; Nakao K; Fujino M; Nagai T; Kanaya T; Tahara Y; Asaumi Y; Tsuda E; Nakai M; Nishimura K; Anzai T; Kusano K; Shimokawa H; Goto Y; Yasuda S
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2350-2355. PubMed ID: 29051141
[TBL] [Abstract][Full Text] [Related]
6. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
Bohula EA; Bonaca MP; Braunwald E; Aylward PE; Corbalan R; De Ferrari GM; He P; Lewis BS; Merlini PA; Murphy SA; Sabatine MS; Scirica BM; Morrow DA
Circulation; 2016 Jul; 134(4):304-13. PubMed ID: 27440003
[TBL] [Abstract][Full Text] [Related]
7. Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice.
Radovanovic D; Pilgrim T; Seifert B; Urban P; Pedrazzini G; Erne P
J Cardiovasc Med (Hagerstown); 2017 May; 18(5):341-347. PubMed ID: 28107211
[TBL] [Abstract][Full Text] [Related]
8. Comparison of one-year outcome of patients aged <75 years versus ≥75 years undergoing "rescue" percutaneous coronary intervention.
De Felice F; Fiorilli R; Parma A; Musto C; Nazzaro MS; Confessore P; Scappaticci M; Cifarelli A; Violini R
Am J Cardiol; 2011 Oct; 108(8):1075-80. PubMed ID: 21791331
[TBL] [Abstract][Full Text] [Related]
9. Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction.
Nestelberger T; Boeddinghaus J; Badertscher P; Twerenbold R; Wildi K; Breitenbücher D; Sabti Z; Puelacher C; Rubini Giménez M; Kozhuharov N; Strebel I; Sazgary L; Schneider D; Jann J; du Fay de Lavallaz J; Miró Ò; Martin-Sanchez FJ; Morawiec B; Kawecki D; Muzyk P; Keller DI; Geigy N; Osswald S; Reichlin T; Mueller C;
J Am Coll Cardiol; 2017 Sep; 70(13):1558-1568. PubMed ID: 28935032
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
[TBL] [Abstract][Full Text] [Related]
11. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
[TBL] [Abstract][Full Text] [Related]
12. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial.
Erne P; Schoenenberger AW; Burckhardt D; Zuber M; Kiowski W; Buser PT; Dubach P; Resink TJ; Pfisterer M
JAMA; 2007 May; 297(18):1985-91. PubMed ID: 17488963
[TBL] [Abstract][Full Text] [Related]
13. Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score.
Polovina M; Đikić D; Vlajković A; Vilotijević M; Milinković I; Ašanin M; Ostojić M; Coats AJS; Seferović PM
Int J Cardiol; 2017 Dec; 249():191-197. PubMed ID: 28986061
[TBL] [Abstract][Full Text] [Related]
14. International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.
Mok Y; Ballew SH; Bash LD; Bhatt DL; Boden WE; Bonaca MP; Carrero JJ; Coresh J; D'Agostino RB; Elley CR; Fowkes FGR; Jee SH; Kovesdy CP; Mahaffey KW; Nadkarni G; Peterson ED; Sang Y; Matsushita K
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982232
[TBL] [Abstract][Full Text] [Related]
15. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
Atanassova PA; Chalakova NT; Dimitrov BD
Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
[TBL] [Abstract][Full Text] [Related]
17. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.
Demers C; McMurray JJ; Swedberg K; Pfeffer MA; Granger CB; Olofsson B; McKelvie RS; Ostergren J; Michelson EL; Johansson PA; Wang D; Yusuf S;
JAMA; 2005 Oct; 294(14):1794-8. PubMed ID: 16219883
[TBL] [Abstract][Full Text] [Related]
18. Six-month cardiovascular prognostic impact of type 1 And type 2 myocardial infarction in patients hospitalized for gastrointestinal bleeding.
Pemmasani G; Ashwath A; Aronow WS; Yandrapalli S; Leighton J; John S
Eur J Intern Med; 2023 Oct; 116():51-57. PubMed ID: 37500309
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus.
Young LH; Viscoli CM; Curtis JP; Inzucchi SE; Schwartz GG; Lovejoy AM; Furie KL; Gorman MJ; Conwit R; Abbott JD; Jacoby DL; Kolansky DM; Pfau SE; Ling FS; Kernan WN;
Circulation; 2017 May; 135(20):1882-1893. PubMed ID: 28246237
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure.
Pitts R; Gunzburger E; Ballantyne CM; Barter PJ; Kallend D; Leiter LA; Leitersdorf E; Nicholls SJ; Shah PK; Tardif JC; Olsson AG; McMurray JJ; Kittelson J; Schwartz GG
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28073769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
